Y-mAbs Therapeutics, Inc. logo YMAB - Y-mAbs Therapeutics, Inc.

Inactive Ticker YMAB is not actively trading. Quotes and analytics may be stale.
Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 8
HOLD 6
SELL 2
STRONG
SELL 0
| PRICE TARGET: $12.71 DETAILS
HIGH: $24.00
LOW: $8.60
MEDIAN: $8.60
CONSENSUS: $12.71
UPSIDE: 47.62%
Annual Quarterly
Metric 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1
Revenue
Revenue 19.5 20.9 26.5 18.5 22.8 19.9 23.4 20.5 20.8 20.3 31.4 12.5 10.8 10.5 9.6 9.0 11.0 5.4 20.8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue 2.7 3.0 7.8 2.2 3.0 2.1 2.0 2.6 4.6 2.1 2.0 2.5 1.2 1.8 1.5 0.6 0.4 0.1 2.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 16.9 17.9 18.7 16.2 19.8 17.8 21.3 17.8 16.1 18.2 29.4 10.1 9.6 8.7 8.1 8.4 10.5 5.3 18.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses
R&D Expenses 11.1 11.4 12.2 11.2 12.3 13.3 13.4 15.4 12.1 13.4 19.8 22.5 26.4 22.9 28.8 23.1 19.8 21.6 24.0 21.0 30.1 18.6 16.8 19.7 14.5 12.5 11.0 8.7 8.3 6.2 6.6 3.1 2.3 2.3
SG&A Expenses 11.3 13.1 12.4 13.6 17.2 11.4 11.1 10.2 11.3 12.3 10.8 13.6 23.1 13.4 15.1 14.0 13.5 12.0 14.6 11.6 10.4 8.1 6.9 4.7 4.1 3.7 3.0 2.7 2.0 1.3 2.6 0.8 0.8 0.8
Other Expenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 2.2 0 0 0 0 0 0 0 0 (0.0) 0 0 0.0 0.0 0 0
Operating Expenses 22.4 24.4 24.6 24.8 29.6 24.7 24.5 25.6 23.3 25.7 30.6 36.1 49.5 36.4 43.9 37.1 33.3 33.5 38.6 32.6 40.5 26.7 23.8 24.4 18.6 16.3 14.1 11.4 10.3 7.5 9.3 3.8 3.0 3.0
Operating Income
Operating Income (5.6) (6.5) (5.9) (8.6) (9.8) (6.9) (3.2) (7.7) (7.2) (7.5) (1.2) (26.0) (39.9) (27.7) (35.8) (28.7) (22.7) (28.3) (20.1) (32.6) (40.5) (26.7) (23.8) (24.4) (18.6) (16.3) (14.1) (11.4) (10.3) (7.5) (9.3) (3.8) (3.1) (3.1)
Interest Expense 0 0 0 0 0 0 0 0 0 0 0 1.5 1.2 0.4 1.1 0.2 0.2 0.3 0.6 0.2 0 0 2.0 0.4 0.6 0 0 0.0 0.0 0.0 0 0 0 0
Interest Income 0 1.4 (1.6) 1.9 0.6 0.4 2.4 0.2 1.1 1.1 2.3 0 0 0 0 0 0 0 0 0 0.1 0.6 0 0 0 0.3 0 0 0 0 0 0 0 0
Profitability
EBITDA (5.6) (5.1) (5.8) (8.4) (9.6) (6.7) (3.0) (7.6) (7.0) (7.3) (0.9) (25.8) (40.9) (27.5) (35.5) (28.6) (22.5) 33.9 (20.0) (32.5) (40.4) (26.7) (23.7) (24.3) (18.6) (16.2) (14.1) (11.4) (10.3) 0 0 0 0.0 0.0
EBIT (3.2) (5.2) (5.9) (8.6) (9.8) (6.9) (3.2) (7.7) (7.2) (7.5) (1.2) (26.0) (41.1) (27.7) (35.8) (28.7) (22.7) 33.8 (20.1) (32.6) (40.5) (26.7) (23.8) (24.4) (18.6) (16.3) (14.1) (11.4) (10.3) (7.5) (9.3) (3.8) (3.1) (3.1)
Income Before Tax (3.2) (5.2) (7.5) (6.7) (9.1) (6.5) (0.8) (7.6) (6.1) (6.4) 1.2 (27.5) (41.1) (28.1) (36.9) (28.9) (22.9) 33.4 (19.9) (32.8) (40.4) (26.2) (23.1) (23.9) (18.0) (15.9) (14.1) (11.4) (10.3) (7.5) (9.3) (3.8) (3.0) (3.0)
Income Tax Expense 0.0 0.0 (0.8) 0.3 0.1 0.2 0.2 0.2 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.0) 0 0 0 0 0 0 0.0 0.0
Net Income (3.2) (5.2) (6.8) (7.0) (9.2) (6.6) (1.0) (7.7) (6.3) (5.1) 1.2 (29.0) (42.3) (28.4) (36.9) (28.9) (22.9) 33.4 (19.9) (32.8) (40.4) (26.2) (23.1) (23.9) (18.0) (15.9) (14.1) (11.4) (10.3) (7.5) (9.3) (3.8) (3.0) (3.0)
Per Share Data
EPS (Basic) -0.07 -0.12 -0.15 -0.16 -0.21 -0.15 -0.02 -0.18 -0.14 -0.12 0.03 -0.66 -0.97 -0.65 -0.85 -0.66 -0.53 0.80 -0.48 -0.82 -1.01 -0.66 -0.61 -0.70 -0.53 -0.47 -0.41 -0.42 -0.32 -0.22 -0.28 -0.11 -0.17 -0.17
EPS (Diluted) -0.07 -0.12 -0.15 -0.16 -0.21 -0.15 -0.02 -0.18 -0.14 -0.12 0.03 -0.66 -0.97 -0.65 -0.85 -0.66 -0.53 0.75 -0.45 -0.82 -1.01 -0.66 -0.58 -0.70 -0.53 -0.47 -0.41 -0.42 -0.32 -0.22 -0.28 -0.11 -0.17 -0.17
Shares Outstanding 45.3 45.1 44.9 44.6 44.0 43.8 43.6 43.6 43.7 43.7 43.7 43.7 43.7 43.7 43.6 43.6 43.3 41.9 41.9 40.2 40.0 39.7 38.0 34.4 34.2 34.2 34.2 27.3 32.6 33.3 33.3 33.3 17.6 17.6
Metric 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q1
Current Assets
Cash & Cash Equivalents 62.3 60.3 67.2 68.1 77.8 75.7 78.6 86.6 87.9 92.6 105.8 114.5 133.7 156.7 181.6 215.7 233.6 252.3 114.6 131.3 158.1 185.8 207.1 98.2 120.2 134.2 147.8 163.3 70.2 (90.5) 90.5 (16.9)
Short-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 181.0 0 33.8
Net Receivables 15.7 17.7 19.7 19.9 38.2 20.6 22.5 18.9 19.1 18.7 12.5 9.3 7.2 9.3 7.7 7.3 8.5 6.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Inventory 9.7 8.0 7.2 9.6 8.5 8.4 5.1 7.1 5.2 8.9 6.7 6.2 6.8 5.6 5.5 4.8 3.8 1.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 4.0 4.4 4.4 1.5 2.2 3.5 5.0 2.3 3.6 3.7 5.5 3.2 6.3 6.1 7.5 2.8 3.4 4.7 7.7 1.9 5.3 4.1 4.8 1.4 3.0 2.8 3.7 2.8 1.6 0 0.9 0
Total Current Assets 91.8 90.4 98.5 99.1 126.8 108.3 111.1 114.9 115.8 124.0 130.4 133.2 153.9 177.7 202.3 230.6 249.4 264.0 122.4 133.2 163.3 189.8 212.0 99.6 123.2 137.0 151.5 166.0 71.7 90.5 91.4 16.9
Non-Current Assets
Property, Plant & Equipment 3.4 0.8 0.9 1.1 1.4 1.3 1.6 1.9 1.6 1.9 2.3 3.5 3.9 4.9 5.7 4.6 5.3 6.1 6.4 7.0 3.7 3.9 4.0 3.8 2.6 2.7 0.2 0.2 0.1 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 2.2 2.2 2.3 2.4 2.5 2.5 2.6 2.7 2.8 2.9 3.0 1.5 1.6 1.6 1.7 1.8 1.8 1.8 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 19.9 19.2 18.3 18.4 13.5 11.2 12.5 9.4 12.2 8.7 5.7 5.6 5.7 6.8 3.2 3.0 3.0 3.0 3.3 3.0 0.4 0.4 0.4 0.3 0.2 0.2 0.2 0.2 1.5 (90.5) 0.8 (16.9)
Total Non-Current Assets 25.4 22.2 21.4 21.9 17.3 15.0 16.8 14.0 16.6 13.4 11.0 10.7 11.3 13.3 10.5 9.4 10.1 10.9 9.7 10.0 4.0 4.2 4.4 4.1 2.9 3.0 0.4 0.3 1.6 (90.5) 0.8 (16.9)
Total Assets 117.2 112.6 119.9 120.9 144.0 123.3 127.9 128.9 132.4 137.4 141.5 143.9 165.2 191.0 212.8 240.0 259.5 274.9 132.0 143.2 167.3 194.1 216.4 103.7 126.0 140.0 151.9 166.4 73.3 0 92.1 0
Current Liabilities
Account Payables 7.6 4.6 6.7 7.9 10.2 6.7 6.1 7.6 7.3 8.8 14.2 13.7 11.3 14.7 13.6 11.0 6.8 6.5 9.4 10.3 9.8 10.3 8.5 7.6 8.9 5.9 5.9 6.8 4.2 0 5.9 0
Short-Term Debt 0.5 0 0 0 0 0.9 0.9 0.9 0.8 0.9 0 1.2 1.1 1.5 0 1.8 0 2.0 0 1.9 0.6 0.5 0 0.5 0.5 0.5 0 0 0 0 0 0
Deferred Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3.4 0 0 0 0 0 0
Other Current Liabilities 11.3 3.3 16.4 16.6 25.9 1.3 8.4 9.6 12.8 11.2 2.4 11.8 11.8 9.4 5.7 6.6 4.5 3.5 3.6 2.0 2.2 1.9 0.4 3.6 2.1 0.5 0 0 0 0 0 0
Total Current Liabilities 22.9 19.0 23.7 25.3 43.5 17.6 20.1 21.8 24.2 25.9 28.3 32.0 29.4 29.0 27.9 25.4 21.0 17 19.5 19.8 15.7 14.8 13.6 14.0 13.6 10.3 9.1 9.3 5.7 0 7.9 0
Non-Current Liabilities
Long-Term Debt 2.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 4.1 4.1 4.0 2.9 4.8 6.2 6.2 6.2 3.1 3.1 3.1 3.0 3.0 2.9 3.0 3.1 3.2 4.2 4.7 4.4 4.2 2.4 2.2 1.9 2.0 2.0 2.3 2.0 2.0 0 2.0 0
Total Non-Current Liabilities 6.8 4.2 4.2 3.2 5.2 6.5 6.8 6.9 3.5 3.7 4.0 4.0 4.3 4.5 4.8 3.8 4.2 5.7 6.7 6.9 5.6 3.9 3.9 3.8 4.0 4.2 2.3 2.0 2.0 0 2.0 0
Total Liabilities 29.7 23.2 27.9 28.5 48.7 24.1 26.9 28.7 27.7 29.6 32.2 36.0 33.8 33.6 32.7 29.1 25.2 22.7 26.2 26.7 21.3 18.7 17.5 17.7 17.7 14.5 11.4 11.4 7.8 0 10.0 0
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0.0 0
Retained Earnings (495.6) (492.3) (487.1) (480.3) (473.3) (464.1) (457.5) (456.5) (448.7) (442.4) (436.0) (437.2) (409.7) (368.5) (340.5) (303.6) (274.7) (251.8) (285.2) (265.3) (232.4) (192.0) (165.9) (142.7) (118.8) (100.8) (84.8) (70.8) (59.3) 0 (41.6) 0
Accumulated Other Comprehensive Income (0.6) 1.4 2.3 (0.0) 1.0 0.8 0.4 1.8 1.0 1.0 1.3 4.7 3.1 1.7 1.4 0.2 (0.0) (0.1) (0.5) (0.0) (0.0) 0.1 0.1 0.1 (0.0) 0.1 0.0 (0.0) (0.1) 82.2 (0.2) 12.1
Total Stockholders' Equity 87.5 89.5 92.0 92.4 95.3 99.2 101.0 100.2 104.7 107.8 109.2 107.9 131.4 157.5 180.1 210.8 234.3 252.2 105.8 116.5 146.0 175.3 198.9 85.9 108.4 125.5 140.5 155.0 65.5 82.2 82.2 12.1
Total Liabilities & Equity 117.2 112.6 119.9 120.9 144.0 123.3 127.9 128.9 132.4 137.4 141.5 143.9 165.2 191.0 212.8 240.0 259.5 274.9 132.0 143.2 167.3 194.1 216.4 103.7 126.0 140.0 151.9 166.4 73.3 82.2 92.1 12.1
Debt Metrics
Total Debt 3.1 0.6 0.8 1.1 1.3 1.2 1.4 1.6 1.2 1.5 1.8 2.2 2.4 3.0 3.6 2.5 3.0 3.5 4.0 4.4 2.0 2.1 2.2 2.3 2.5 2.6 0 0 0 0 0 0
Net Debt (59.2) (59.7) (66.4) (67.0) (76.5) (74.6) (77.2) (84.9) (86.7) (91.1) (104.0) (112.3) (131.3) (153.7) (177.9) (213.2) (230.6) (248.8) (110.7) (126.9) (156.1) (183.7) (204.9) (95.9) (117.7) (131.6) (147.8) (163.3) (70.2) 90.5 (90.5) 16.9
Metric 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1
Operating Activities
Net Income (3.2) (5.2) (6.8) (7.0) (9.2) (6.6) (1.0) (7.7) (6.3) (6.4) 1.2 (27.5) (41.1) (28.1) (36.9) (28.9) (22.9) 33.4 (19.9) (32.8) (40.4) (26.2) (23.1) (23.9) (18.0) (15.9) (14.1) (11.4) (10.3) (7.5) (9.3) (3.8) (3.0) (3.0)
Depreciation & Amortization 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0 0 0 0 0
Stock-Based Compensation 2.9 3.3 3.1 4.2 3.4 3.8 3.1 2.5 3.6 5.3 3.5 3.3 13.6 5.1 4.9 4.9 4.8 4.7 8.3 3.1 2.5 2.2 1.5 1.3 1.0 0.9 0.5 0.4 0.9 0.2 0.2 0.2 0.1 0.1
Change in Working Capital 3.9 (4.3) (1.2) (4.4) 5.7 (1.3) (9.4) 3.5 (2.0) (11.8) (13.5) 2.8 2.8 (2.5) (3.3) 5.5 (0.9) (8.5) (5.7) 5.5 1.6 2.1 (2.9) 1 3.1 1.5 (0.0) 1.8 (2.5) 0.7 2.8 1.0 (0.2) (0.2)
Other Non-Cash Items (1.9) (0.8) 3.0 (3.6) 0.2 0.5 2.4 0.3 (1.4) (0.5) (0.1) 2.0 1.4 0.3 1.1 0.2 0.1 (62.0) (0.5) 0.0 8.6 0.0 (0.1) 0.1 (0.1) 0.1 (0.0) 0.0 0.1 0.0 (0.0) (0.1) (0.3) (0.3)
Operating Cash Flow 1.7 (6.9) (1.9) (10.7) 0.3 (3.5) (8.0) (1.3) (4.7) (13.1) (8.7) (19.2) (23.1) (24.9) (33.9) (18.1) (18.8) (31.9) (17.7) (24.1) (27.6) (21.8) (24.6) (21.4) (14.0) (13.5) (13.6) (9.2) (11.9) (6.6) (6.3) (2.7) (3.4) (3.4)
Investing Activities
Capital Expenditure 0 (0.1) 0 0 0 0 0 0 0 0 0 0 0 0 (0.5) (0.1) (0.0) (0.4) (0.0) (0.1) (0.0) (0.0) (1.1) (0.6) (0.1) (0.1) (0.1) (0.1) (0.1) 0 0 0 0 0
Acquisitions 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sales/Maturities of Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Investing Activities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.3) 0 0 62.0 0 (2.6) 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Investing Cash Flow 0 (0.1) 0 0 0 0 0 0 0 0 0 0 0 0 (0.5) (0.1) (0.0) 61.6 (0.0) (2.7) (0.0) (0.0) (1.1) (0.6) (0.1) (0.1) (0.1) (0.1) (0.1) 0 (0.0) 0.0 0 0
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0.0 0.1 0.2 0.1 0.1 1.4 0.2 0 0.4 0 0 0 0 0 (0.2) (0.1) (1.6) (0.2) (0.0) 5.1 5.1
Financing Cash Flow 0.3 0.1 1.0 1.0 1.8 0.6 0.1 0 0 0 0 0.1 0 0.0 0.1 0.2 0.1 107.8 1.4 0.2 0 0.4 134.7 0 0 0 (1.8) 102.4 (0.1) (1.6) 65.1 14.3 5.1 5.1
Cash Position
Net Change in Cash 2.0 (6.9) (0.9) (9.7) 2.1 (2.9) (7.9) (1.3) (4.7) (13.1) (8.8) (19.1) (23.1) (24.8) (34.2) (17.9) (18.7) 137.6 (16.6) (26.8) (27.7) (21.4) 108.9 (22.0) (14.1) (13.6) (15.5) 93.2 (12.1) (8.3) 58.8 11.7 1.6 1.6
Cash at Beginning 60.3 67.2 68.1 77.8 75.7 78.6 86.6 87.9 92.6 105.8 114.5 133.7 156.7 181.6 215.7 233.6 252.3 114.6 131.3 158.1 185.8 207.1 98.2 120.2 134.3 147.9 163.3 70.2 82.2 90.5 31.7 20.1 18.5 0
Cash at End 62.3 60.3 67.2 68.1 77.8 75.7 78.6 86.6 87.9 92.6 105.8 114.5 133.7 156.7 181.6 215.7 233.6 252.3 114.6 131.3 158.1 185.8 207.1 98.2 120.2 134.3 147.9 163.3 70.2 82.2 90.5 31.7 20.1 1.6
Free Cash Flow 1.7 (7.0) (1.9) (10.7) 0.3 (3.5) (8.0) (1.3) (4.7) (13.1) (8.7) (19.2) (23.1) (24.9) (34.3) (18.1) (18.8) (32.3) (17.7) (24.2) (27.6) (21.8) (25.7) (22.0) (14.1) (13.6) (13.6) (9.2) (12.0) (6.6) (6.3) (2.7) (3.4) (3.4)
Key Metrics 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1
Income Statement
Revenue 19.5 20.9 26.5 18.5 22.8 19.9 23.4 20.5 20.8 20.3 31.4 12.5 10.8 10.5 9.6 9.0 11.0 5.4 20.8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 16.9 17.9 18.7 16.2 19.8 17.8 21.3 17.8 16.1 18.2 29.4 10.1 9.6 8.7 8.1 8.4 10.5 5.3 18.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Income (5.6) (6.5) (5.9) (8.6) (9.8) (6.9) (3.2) (7.7) (7.2) (7.5) (1.2) (26.0) (39.9) (27.7) (35.8) (28.7) (22.7) (28.3) (20.1) (32.6) (40.5) (26.7) (23.8) (24.4) (18.6) (16.3) (14.1) (11.4) (10.3) (7.5) (9.3) (3.8) (3.1) (3.1)
Net Income (3.2) (5.2) (6.8) (7.0) (9.2) (6.6) (1.0) (7.7) (6.3) (5.1) 1.2 (29.0) (42.3) (28.4) (36.9) (28.9) (22.9) 33.4 (19.9) (32.8) (40.4) (26.2) (23.1) (23.9) (18.0) (15.9) (14.1) (11.4) (10.3) (7.5) (9.3) (3.8) (3.0) (3.0)
EPS (Diluted) -0.07 -0.12 -0.15 -0.16 -0.21 -0.15 -0.02 -0.18 -0.14 -0.12 0.03 -0.66 -0.97 -0.65 -0.85 -0.66 -0.53 0.75 -0.45 -0.82 -1.01 -0.66 -0.58 -0.70 -0.53 -0.47 -0.41 -0.42 -0.32 -0.22 -0.28 -0.11 -0.17 -0.17
Balance Sheet
Cash & Equivalents 62.3 60.3 67.2 68.1 77.8 75.7 78.6 86.6 87.9 92.6 105.8 114.5 133.7 156.7 181.6 215.7 233.6 252.3 114.6 131.3 158.1 185.8 207.1 98.2 120.2 134.2 147.8 163.3 70.2 (90.5) 90.5 (16.9)
Total Assets 117.2 112.6 119.9 120.9 144.0 123.3 127.9 128.9 132.4 137.4 141.5 143.9 165.2 191.0 212.8 240.0 259.5 274.9 132.0 143.2 167.3 194.1 216.4 103.7 126.0 140.0 151.9 166.4 73.3 0 92.1 0
Total Debt 3.1 0.6 0.8 1.1 1.3 1.2 1.4 1.6 1.2 1.5 1.8 2.2 2.4 3.0 3.6 2.5 3.0 3.5 4.0 4.4 2.0 2.1 2.2 2.3 2.5 2.6 0 0 0 0 0 0
Stockholders' Equity 87.5 89.5 92.0 92.4 95.3 99.2 101.0 100.2 104.7 107.8 109.2 107.9 131.4 157.5 180.1 210.8 234.3 252.2 105.8 116.5 146.0 175.3 198.9 85.9 108.4 125.5 140.5 155.0 65.5 82.2 82.2 12.1
Cash Flow
Operating Cash Flow 1.7 (6.9) (1.9) (10.7) 0.3 (3.5) (8.0) (1.3) (4.7) (13.1) (8.7) (19.2) (23.1) (24.9) (33.9) (18.1) (18.8) (31.9) (17.7) (24.1) (27.6) (21.8) (24.6) (21.4) (14.0) (13.5) (13.6) (9.2) (11.9) (6.6) (6.3) (2.7) (3.4) (3.4)
Capital Expenditure 0 (0.1) 0 0 0 0 0 0 0 0 0 0 0 0 (0.5) (0.1) (0.0) (0.4) (0.0) (0.1) (0.0) (0.0) (1.1) (0.6) (0.1) (0.1) (0.1) (0.1) (0.1) 0 0 0 0 0
Free Cash Flow 1.7 (7.0) (1.9) (10.7) 0.3 (3.5) (8.0) (1.3) (4.7) (13.1) (8.7) (19.2) (23.1) (24.9) (34.3) (18.1) (18.8) (32.3) (17.7) (24.2) (27.6) (21.8) (25.7) (22.0) (14.1) (13.6) (13.6) (9.2) (12.0) (6.6) (6.3) (2.7) (3.4) (3.4)